20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Understanding the Pricing and Purchase of Escitalopram Intermediate (128173-53-5)

For pharmaceutical procurement specialists and R&D scientists, understanding the factors that influence the pricing and purchase of key chemical intermediates is crucial for effective budgeting and supply chain management. The compound with CAS number 128173-53-5, known as (-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt, is a vital intermediate in the synthesis of Escitalopram.

When looking to buy this essential pharmaceutical intermediate, many buyers search for 'pharmaceutical intermediate price' to gauge market rates and identify cost-effective sourcing options. As a dedicated manufacturer and supplier, we strive to offer competitive pricing for this high-purity Escitalopram intermediate. Factors such as order volume, purity requirements, and current market demand all play a role in the final price. We encourage potential clients to inquire about bulk purchase discounts and long-term supply agreements to secure the best possible rates.

The purchase process for this critical compound typically involves requesting a quote and potentially a sample for quality verification. Searching for 'Escitalopram Related Compound A supplier China' or 'buy 128173-53-5' are common starting points. As a reliable China manufacturer, we aim to make this process as straightforward as possible. Our team is ready to assist with inquiries regarding specifications, lead times, and payment terms, ensuring a smooth transaction from inquiry to delivery.

We understand that a stable supply chain is as important as competitive pricing. By choosing us as your supplier, you are partnering with a manufacturer committed to consistent quality and timely delivery, which is fundamental for uninterrupted pharmaceutical production. For those engaged in 'custom synthesis 128173-53-5' or requiring large quantities, our established infrastructure and expertise ensure we can meet your demands efficiently. Securing your supply of this vital intermediate today means ensuring the continuity and quality of your pharmaceutical manufacturing processes.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: China Manufacturer for Escitalopram Precursor: CAS 128173-53-5

Next: Ensuring API Synthesis Success with High-Purity Escitalopram Intermediate

All Rights Reserved